Skip to Main Content

1,689

Views

0

CrossRef citations to date

0

Altmetric

Original Articles

No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib

Jacqueline C. Barrientosa Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USACorrespondence[email protected]
View further author information

,

Peter Hillmenb St. James’s University Hospital, Leeds, UKView further author information

,

Gilles Sallesc Hospices Civils de Lyon, University Claude Bernard, Pierre Benite, FranceView further author information

,

Jeff Sharmand Willamette Valley Cancer Institute and Research Center/US Oncology Research, Springfield, OR, USAView further author information

,

Stephan Stilgenbauere Department of Medicine III, University of Ulm, Ulm, GermanyView further author information

,

Oksana Gurtovayaf Gilead Sciences, Inc, Foster City, CA, USAView further author information

,

Guan Xingf Gilead Sciences, Inc, Foster City, CA, USAView further author information

,

Bianca Ruzickaf Gilead Sciences, Inc, Foster City, CA, USAView further author information

,

Pankaj Bhargavaf Gilead Sciences, Inc, Foster City, CA, USAView further author information

,

Paolo Ghiag Università Vita-Salute San Raffaele and IRCCS Instituto Scientifico San Raffaele, Milano, ItalyView further author information

&

John M. Pagelh Swedish Cancer Institute, Seattle, WA, USAView further author information